Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

A.M.L. spectacle lenses for children with myopia

Official title: An Evaluation of Visual Comfort, Adaptation and Overall Satisfaction in Myopic Children Using A.M.L. Series of Lenses

Run by Essilor International · NCT07354945 · Data updated 2026-11-12

We will try A.M.L. spectacle lenses in 6- to 12-year-old children with myopia to see how quickly they adapt and how comfortable the lenses feel.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment40 (estimated)
SponsorEssilor International
Industry-sponsored
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedJanuary 2, 2026
Main results expectedFebruary 25, 2026
Study endsApril 27, 2026
Registry record updatedJanuary 23, 2026
Trial IDNCT07354945 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6 to 12 years with cycloplegic spherical equivalent between −0.50 D and −4.75 D, astigmatism ≤2.00 D, anisometropia ≤1.50 D, best-corrected visual acuity ≥ +0.10 LogMAR in each eye, good general health, and parental consent/child assent are eligible.

Probably not a fit

Children with higher myopia outside the specified range, significant astigmatism, amblyopia, strabismus, prior atropine/orthokeratology/red-light treatment, or other ocular/systemic conditions affecting refraction are unlikely to benefit from this specific test.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm, prospective interventional study enrolling 40 myopic children aged 6–12 years who will wear the A.M.L. series spectacle lenses for two weeks. Participants will be seen at day 4–6, week 1, and week 2 to record adaptation, wearing comfort, visual quality, and user satisfaction. Eligibility requires cycloplegic spherical equivalent between −0.50 D and −4.75 D, astigmatism ≤2.00 D, anisometropia ≤1.50 D, and best-corrected visual acuity ≥ +0.10 LogMAR in each eye. The study aims to document how many children adapt within 4–6 days and to characterize short-term wearing experience with these microlens-design myopia-control spectacles.

Why it matters

Potential benefit: If successful, these lenses could make spectacles more comfortable and easier for children with myopia to wear, potentially improving daily vision and adherence to correction.

How similar studies have gone: Other spectacle lenses using optical-defocus microlens designs have shown efficacy in slowing myopia and prior adaptation studies exist, but there are no published data specifically on the A.M.L. series.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Volunteer participant
* Informed consent of parent/guardian and assent of participant
* Age equal to or greater than 6 years and not older than 12 years at the time of signing informed consent and assent
* Spherical equivalent refraction (SER) by cycloplegic autorefraction equal or less than -0.50 D and equal or greater than -4.75D with astigmatism not more than 2.00 D on both eye
* Difference in SER (anisometropia) between two eyes should not exceed 1.50 D
* Best corrected visual acuity (BCVA) better than or equal to +0.10 LogMAR in each eye
* Be in good general health, based on the participant and the parent's/guardian's knowledge
* Willingness and ability to participate in study and comply with all scheduled visits

Exclusion Criteria:

* History of Atropine, Orthokeratology, or Red Light treatment
* Strabismus by cover test at near or distance wearing correction
* Amblyopia
* Any ocular or systemic condition known to affect refractive status (e.g. keratoconus, diabetes, Downs syndrome, or other developmental disorders, etc.)
* Current use of ocular or systemic medications which, in the investigator's opinion, may significantly affect pupil size, accommodation or refractive state
* History of ocular injury or surgery
* Participation in any clinical study within 30 days of the Baseline visit
* Study participants deemed inappropriate for the study by the investigator
* The inherent ocular/systemic discomfort (dry eyes, visual fatigue, headaches, etc.) that may affect the evaluation of the study lens wearing experience, from the investigator's perspective

Where it's running

  • Shanghai Meishimeijing Ophthalmology Clinic Co., Ltd.
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.